New Year Bumper Sale @ Rs. 1 X
Cavirip is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Tuberculosis.
Medical history of the patient along with age and gender determines the dosage of Cavirip. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The most common side effects of Cavirip are Rash, Erythema, Discoloration of Urine. Apart from the aforementioned side effects, Cavirip can also lead to other problems, which have been listed below. Usually, these side effects of Cavirip go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Cavirip's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Cavirip related warnings talks about Cavirip's effects on the liver, heart and kidney.
The section on Cavirip contraindications lists all such conditions.
Drug reaction of Cavirip with other medicines has been reported. See below for a complete list.
You should also be aware that Cavirip is not safe while driving, and is not addiction.
Cavirip is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Cavirip is used -
Moderate
Common
Is the use of Cavirip safe for pregnant women?
Cavirip can have harmful effects in pregnant women. If you experience any discomfort after using Cavirip, then discontinue the use and take your doctor's advice.
Is the use of Cavirip safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Cavirip. Immediately discontinue Cavirip if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Cavirip on the Kidneys?
There may be some adverse effects on kidney after taking Cavirip. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Cavirip on the Liver?
There may be an adverse effect on the liver after taking Cavirip. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Cavirip on the Heart?
Cavirip may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Cavirip should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Cavirip unless your doctor advises you to do so -
Is this Cavirip habit forming or addictive?
Cavirip does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Cavirip you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Cavirip should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Cavirip in mental disorders is not effective.
Interaction between Food and Cavirip
You can take Cavirip with food.
Interaction between Alcohol and Cavirip
Taking alcohol with Cavirip can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
Product Description [Internet]: RIFATER® (rifampin, isoniazid and pyrazinamide USP). USFDA
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited